DOI:
10.1055/s-00000025
Hormone and Metabolic Research
LinksClose Window
References
Okura Y, Namisaki T, Moriya K. et al.
Combined treatment with dipeptidyl peptidase-4 inhibitor (sitagliptin) and
angiotensin-II type 1 receptor blocker (losartan) suppresses progression in a
non-diabetic rat model of steatohepatitis.
Hepatol Res 2017;
47: 1317-1328
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.